Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8921519 Single chain fusion polypeptides comprising soluble light cytokine domains

Patent 8921519 was granted and assigned to Apogenix on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Oliver Hill0

Christian Gieffers0

Meinolf Thiemann0

Date of Patent

December 30, 2014

0

Patent Application Number

139023280

Date Filed

May 24, 2013

0

Patent Citations Received

US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells

0

US Patent 11713446 Processes for generating TIL products enriched for tumor antigen-specific T-cells

0

US Patent 11866688 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

0

US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment

0

US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

0

US Patent 12071465 Methods of making and using extracellular domain-based chimeric proteins

0

Patent Primary Examiner

Robert Landsman

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8921519 Single chain fusion polypeptides comprising soluble light cytokine domains

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool